{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:29:06Z","timestamp":1790051346100,"version":"4.0.1"},"reference-count":15,"publisher":"Wiley","license":[{"start":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T00:00:00Z","timestamp":1545264000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Case Reports in Hematology"],"published-print":{"date-parts":[[2018,12,20]]},"abstract":"<jats:p>Ipilimumab is a monoclonal antibody that enhances the efficacy of the immune system by targeting a cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), which is a protein receptor that downregulates the immune system. Nivolumab is also a humanized monoclonal antibody that targets another protein receptor that prevents activated T cells from attacking the cancer; this receptor is called programmed cell death 1 (PD-1). The FDA approved ipilimumab combined with nivolumab as a frontline therapy for patients with metastatic melanoma or renal cell carcinoma and as a second-line therapy for patients with microsatellite instability-high (MSI-H) metastatic colon cancer. Immune-related adverse events such as autoimmune colitis, pneumonitis, hepatitis, nephritis, hypophysitis, and thyroiditis may occur during or weeks to months after therapy. We report a case of thrombotic thrombocytopenic purpura (TTP) in a patient with metastatic renal cell carcinoma following one cycle of ipilimumab and nivolumab. Only one case report of ipilimumab-induced TTP exists in the medical literature. With the wide use of immunotherapy to treat cancers, physicians need to be aware of this rare immune-related adverse event.<\/jats:p>","DOI":"10.1155\/2018\/2464619","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T18:32:02Z","timestamp":1545330722000},"page":"1-4","source":"Crossref","is-referenced-by-count":18,"title":["Thrombotic Thrombocytopenic Purpura due to Checkpoint Inhibitors"],"prefix":"10.1155","volume":"2018","author":[{"given":"Alexey","family":"Youssef","sequence":"first","affiliation":[{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawara","family":"Kasso","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tishreen University, Lattakia, Syria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Sergio","family":"Torloni","sequence":"additional","affiliation":[{"name":"Medical Director, Stem Cell Therapy, Apheresis, and Transfusion Medicine, Banner MD Anderson Cancer Center, Gilbert, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stanek","sequence":"additional","affiliation":[{"name":"Division of Hematology, Banner MD Anderson Cancer Center, Gilbert, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomislav","family":"Dragovich","sequence":"additional","affiliation":[{"name":"Chief, Division of Medical Oncology and Hematology, Banner MD Anderson Cancer Center, Gilbert, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gimbel","sequence":"additional","affiliation":[{"name":"The T.W. Lewis Melanoma Center of Excellence, Banner MD Anderson Cancer Center, Gilbert, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1662-1640","authenticated-orcid":true,"given":"Fade","family":"Mahmoud","sequence":"additional","affiliation":[{"name":"The T.W. Lewis Melanoma Center of Excellence, Banner MD Anderson Cancer Center, Gilbert, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-709857"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra020528"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2010.076349"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2014.03.013"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.a2142"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1177\/1078155215572932"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504030"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1712126"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k793"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv383"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0224-7"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1097\/md.0b013e3182603598"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"issue":"23","key":"14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1182\/blood.V126.23.106.106","volume":"126","year":"2015","journal-title":"Blood"},{"issue":"23","key":"15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1182\/blood.V126.23.107.107","volume":"126","year":"2015","journal-title":"Blood"}],"container-title":["Case Reports in Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/crihem\/2018\/2464619.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/crihem\/2018\/2464619.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/crihem\/2018\/2464619.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T16:20:12Z","timestamp":1573575612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/crihem\/2018\/2464619\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,20]]},"references-count":15,"alternative-id":["2464619","2464619"],"URL":"https:\/\/doi.org\/10.1155\/2018\/2464619","relation":{},"ISSN":["2090-6560","2090-6579"],"issn-type":[{"value":"2090-6560","type":"print"},{"value":"2090-6579","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,20]]}}}